Osteoarthritis is the most common chronic condition affecting older persons. This condition is probably not a single disease but rather "a group of overlapping distinct diseases, which may have different etiologies but with similar biologic, morphologic, and clinical outcomes" A common final result of these diseases, however, is the degeneration...
Combination of proprietary drug targetsand unique technologies to create range of new therapeutic antibodies. Click here to access the live audio webcast presentation at 14.00CET/8:00 AM EST, call number +32.2.401.53.06, or toll free from the US1.866.931.1567 Mechelen, Belgium and Munich, Germany; 26 November...
MorphoSys AG (FSE: MOR; Prime StandardSegment, TecDAX) and Galapagos NV (Euronext: GLPG) announced today thelaunch of a long term co-development alliance aimed at discovering anddeveloping antibody therapies based on novel modes of action in bone andjoint disease, including rheumatoid arthritis, osteoporosis andosteoarthritis. The alliance spans all activities from target discovery...
First CINOD Meets all Three Co-primary Endpoints (p<0.001) in the 303 Hip Osteoarthritis OA Study and Shows no Detrimental Effect on Blood Pressure SOPHIA ANTIPOLIS, France, November 24 /PRNewswire-FirstCall/ -- NicOx S.A. (NYSE Euronext Paris: COX) today announced that the third pivotal phase 3 study for naproxcinod...
First CINOD meets all three co-primary endpoints (p < 0.001) in the 303 hip osteoarthritis OA study andshows no detrimental effect on blood pressure November 24, 2008. Sophia Antipolis, France. www.nicox.com NicOx S.A. (NYSE Euronext Paris: COX) today announced that the thirdpivotal phase 3 study for naproxcinod in...
A live surgical webcast of MAKOplasty®robotic arm partial knee resurfacing will be presented by Thomas M. Coon,M.D. and St. Elizabeth Community Hospital on December 1st at 3:00 p.m. PST.MAKOplasty® is a new, minimally invasive partial knee resurfacingprocedure used to treat early tomid-stage knee osteoarthritis that offers a more precise and...
Byline: By KATY SIMPSON COLD-HEARTED bus users left this disabled passenger stranded after he fell over on his crutches. Osteoarthritis sufferer Christian Dawson, of Blaydon, today told of his anger as commuters rushed past while he helplessly struggled in pain and humiliation on the floor. ...
Study did not achieve statistical significance ISELIN, N.J., Nov. 19 /PRNewswire-FirstCall/ -- Pharmos Corporation today announced results from its Phase 2a clinical trial of its topical NanoEmulsion NE drug delivery technology formulated with 3% Diclofenac Diethanolamine. The multi-center, randomized, double-blinded, placebo-controlled study evaluated the...
More than 70,000 people across the world withosteoarthritis have undergone a hip resurfacing procedure with theBIRMINGHAM HIPTM resurfacing system. Using a specialized instrument, thesurgeon will remove the damaged surface of the socket to tightly support ahighly polished metal cup. The femur is similarly prepared for a polishedmetal cap, preserving much...
Q: I am approaching 88. Both knees are bothering me. What kind of medication, ointments, therapy and exercise can be used to prevent surgery? A: I assume you have osteoarthritis -- the most common kind of arthritis, the kind most older people have at least a touch...
PARSIPPANY, N.J., Nov. 12 /PRNewswire/ -- Ferring Pharmaceuticals Inc. announces the promotion of William N. Garbarini, Jr. to Vice President of its new Orthopaedics and Urology Business Unit, recently formed by merging these clinical product areas. Garbarini was formerly Executive Director of Ferring's Orthopaedics Business Unit. ...
MOUNTAIN VIEW, Calif., Nov. 11 /PRNewswire/ -- The 2008 Frost & Sullivan European Health Ingredient of the Year Award is presented to GELITA AG in recognition of its pioneering efforts in developing the novel ingredient FORTIGELR to treat joint health problems. "Rather than cure, current medical treatments...
MENLO PARK, Calif. -- Geron Corporation (Nasdaq:GERN) today announced that Thomas B. Okarma, Ph.D., M.D., president and chief executive officer, will present an update of the company's human embryonic stem cell development programs at 12:00 p.m. ET on Wednesday, November 12, 2008, at the Rodman & Renshaw Annual Global Investment...
VERNON HILLS, Ill. -- Winston Laboratories, Inc., a wholly owned subsidiary of Getting Ready Corporation (OTC: GTRY.OB), announced that on October 30, 2008 it entered into a licensing agreement with sanofi-aventis Canada Inc. for the Canadian rights to Winston's proprietary transient receptor potential vanilloid (TRPV-1) modulator in formulations for topical...
More than 70,000 people across the world withosteoarthritis have undergone a hip resurfacing procedure with theBIRMINGHAM HIPTM resurfacing system. Using a specialized instrument, thesurgeon will remove the damaged surface of the socket to tightly support ahighly polished metal cup. The femur is similarly prepared for a polishedmetal cap, preserving much...
-- Synavive[TM] Phase 2b Osteoarthritis Trial Results Reported; Additional Phase 2 Data Points Expected on Pipeline Programs; Organization Restructured to Conserve Cash While Continuing to Invest in Pipeline -- CAMBRIDGE, Mass. -- CombinatoRx, Incorporated (NASDAQ: CRXX) today reported financial results for the third quarter ended September 30, 2008....
November 4, 2008. SophiaAntipolis, France. www.nicox.com NicOx S.A. (Euronext Paris: COX) today announced positive top-line resultsfrom a 118 patient Ambulatory Blood Pressure Monitoring ABPM trial (the111 study), which compared the 24-hour blood pressure profile of escalatingdoses of naproxcinod and naproxen in osteoarthritis OA patients withcontrolled hypertension. The primary...
SOPHIA ANTIPOLIS, France, November 4 /PRNewswire-FirstCall/ -- NicOx S.A. (Euronext Paris: COX) today announced positive top-line results from a 118 patient Ambulatory Blood Pressure Monitoring ABPM trial (the 111 study), which compared the 24-hour blood pressure profile of escalating doses of naproxcinod and naproxen in osteoarthritis OA patients with...
U.S. District Court, Western District of N.Y Social Security Hussain v. Astrue 07-CV-210 Judge Curtin Background: The plaintiff is 34 years old and applied for disability benefits from residual pain due to a car accident...
An alternative to total hip replacement surgery, hip resurfacing isn't for everyone. But for younger, more athletic patients who chafe at potential activity restrictions following hip surgery, the bone-sparing alternative may be just what the doctor ordered. That was Mats Kinnison's theory. The 53-year-old mortgage banker had...
Articles 2008-10-27
<< Previous
page 1 of 1
Next >>
Premier Vendor Content
Whitepapers, webcasts & resources from our Power Center Sponsors
Powerful, Dell is built to fit your business needs Customized systems, experts trained in small business, 24/7/365 support, and powerful, reliable technology. Dell, big results for small business.
